Aivita Biomedical, Inc.
7 clinical trials · Sponsor
◉ Watch Aivita Biomedical, Inc.
| Record | Firm | Date |
|---|---|---|
| AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM (NCT05100641) | Aivita Biomedical, Inc. | 2024-01-01 |
| Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults (NCT04386252) | Aivita Biomedical, Inc. | 2023-01-01 |
| Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma (NCT03743298) | Aivita Biomedical, Inc. | 2021-04-21 |
| Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19 (NCT05007496) | Aivita Biomedical, Inc. | 2021-04-14 |
| Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection (NCT04690387) | Aivita Biomedical, Inc. | 2020-12-07 |
| Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma (NCT03400917) | Aivita Biomedical, Inc. | 2018-06-20 |
| Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas (NCT02033616) | Aivita Biomedical, Inc. | 2017-11-18 |
Track Aivita Biomedical, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.